RxDoctor Payments Data

Charles Herbst

Rheumatology · Erie, PANPI 1437145737

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $27,613 of the $32,199 with a category attached, or 85.8%. AbbVie accounts for 93.7% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $28,208 and has fallen 98.7% since, to $357 in 2021.

$32,199in general payments, 2019–2025

Across 212 payments — averaging $151.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$30K
  • Johnson & Johnson$835
  • Amgen$335
  • Pfizer$249
  • GSK$160
  • Novartis$142
  • plus $298 from 7 others

What the payments were for

  • Speaking & faculty fees$27,61386%
  • Travel & lodging$1,5075%
  • Food & beverage$3,07910%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,199 in reported general payments places this provider in the 85th percentile of 351 rheumatology providers in Pennsylvania.

See all rheumatology providers in Pennsylvania →

Other rheumatology in Erie

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →